Wakefield AJ, 1998, Lancet, 351, 637, 10.1016/S0140-6736(97)11096-0
Coffin SE., 2002, Expert Rev. Vaccines, 1, 145, 10.1586/14760584.1.2.145
Madsen KM, 2002, N Engl. J. Med, 347, 1477, 10.1056/NEJMoa021134
Wakefield AJ, 2000, Adverse Drug Res, 19, 1
Makela A, 2002, Neurologic disorders after measles—mumps—rubella vaccination. Pediatrics, 110, 957
Geier MR, 2003, Int. Pediatr, 18, 108
Ellenberg SS, 1997, Public Health Rep, 112, 10
Pless RP Recent differing expert opinions regarding the safety profile of hepatitis B vaccines, 2003, Drug Saf, 2, 451
Mann JR, 2003, Biol. Med, 228, 991, 10.1177/153537020322800901
10.1016/0140-6736(92)92873-E
Kilroy AW, 1970, Two syndromes following rubella immunization. Clinical observations and epidemiological studies. JANIA, 214, 2287
Wakefield AJ, 2000, Am. J. Gastroenterol, 95, 2285, 10.1111/j.1572-0241.2000.03248.x
Taylor B, 1999, Lancet, 353, 2026, 10.1016/S0140-6736(99)01239-8
Farrington CP, 2001, Vaccine, 19, 3632, 10.1016/S0264-410X(01)00097-4
Murch S, 2003, Lancet, 362, 1498, 10.1016/S0140-6736(03)14699-5
Taylor B, 2002, Br. Med, 324, 393, 10.1136/bmj.324.7334.393
Morris A, 2002, Pathol Mal Pathol, 55
Korvatska E, 2002, Neurobial Dis, 9, 107, 10.1006/nbdi.2002.0479
Singh VK, 2003, Pediatr. Neural, 28, 292, 10.1016/S0887-8994(02)00627-6
Jansen VAA, 2003, Science, 301, 804, 10.1126/science.1086726
